Global Taxifolin Market Strategic Research Report

Scope of the Report

The global Taxifolin market size is predicted to grow from US$ 30.87 million in 2025 to US$ 40.51 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.

In 2024, global taxifolin sales will reach 20,000 kg, with an average selling price of approximately US$1,300/kg.Taxifolin, also known as dihydroquercetin, is a natural flavonoid found in plants as diverse as Siberian larch, milk thistle, and onion. It is known for its potent antioxidant, anti-inflammatory, and anti-aging properties, making it a popular ingredient in dietary supplements and skincare products. Taxifolin is structurally similar to the well-known flavonoid quercetin, but boasts greater water solubility and stability, enhancing its bioavailability and therapeutic potential. Research suggests it may support cardiovascular health, improve immune function, and protect cells from oxidative stress.

Global key taxifolin players include Ametis, ROBIOS and JW Health Products etc. The top 3 companies hold a share about 96%. Asia-Pacific is the largest market with a share about 34%, followed by Europe and America. In terms of product, the product whose purity is below 92% is the largest segment with a share about 72%. And in terms of applications, the largest application is healthcare with a share about 40%.

The main drivers of the taxusin market include the following:

1. Explosive demand in the pharmaceutical sector and expansion of clinical applications

1. Expansion of core ingredients and indications for anticancer drugs

Significant anticancer effects: Taxusin, a natural anticancer active ingredient, is highly effective in treating solid tumors such as breast and ovarian cancer. The global market size is expected to reach US$920 million in 2023, with China accounting for 28%. Targeted drug development is accelerating, with the number of clinical trials for indications such as lung and gastric cancer increasing 3.2-fold compared to 2020. It is expected that these drugs will contribute an incremental market share of 800 million to 1 billion yuan in 2025.

Policy support and medical insurance coverage: The National Medical Products Administration's "Technical Guidelines for Priority Review of Anticancer Drugs" has fast-tracked taxusin compound preparations, shortening the approval cycle to 180 working days. Dynamic adjustments to the medical insurance catalog have increased the reimbursement rate for paclitaxel-based drugs from 65% to 82%, reducing annual treatment costs for patients to 32,000 to 48,000 yuan, significantly improving drug accessibility. 2. Formulation Technology Innovation and R&D Investment

New Drug Delivery Systems: New drug delivery methods such as liposome delivery systems and nanocrystal technology have increased bioavailability by 40%-60% and reduced drug toxicity and side effects by approximately 30%.

II. Consumption Upgrade in the Health Products and Cosmetics Market

1. Surge in Demand for Natural Antioxidants

Rising Health Awareness: Global awareness of chronic diseases and oxidative stress-related conditions is increasing, driving consumer demand for natural antioxidants and health supplements.

Functional Foods and Agricultural Applications

2. Efficacy Breakthroughs in Cosmetics

Anti-Aging and Whitening Effects: Taxifolin at a concentration of 0.5% can increase skin elasticity by 27% and reduce wrinkle depth by 33% for eight weeks. It also non-competitively inhibits tyrosinase activity, surpassing arbutin in effectiveness.

High-End Brand Applications: Brands such as Proya use it as a core ingredient, driving price premiums of 300%-500% for related products. Medical dressings are used for post-laser surgery repair, reducing erythema and hyperpigmentation. III. Technological Advances and Cost Optimization Drive Industrialization

1. Extraction Technology Breakthroughs and Environmental Compliance

Supercritical CO₂ Extraction Technology: The penetration rate will increase from 18% in 2020 to 43% in 2025, with residual solvent levels reduced to below 0.02 ppm. The number of companies meeting European and American cGMP standards will increase by 300%.

Synthetic Biology and Cell Culture: Chemical synthesis (semi-synthesis and total synthesis) has become the mainstream preparation method due to its low cost and high yield. A listed company's 50-ton bioreactor production line has increased extraction efficiency by 12-fold and reduced single-cycle production costs by 58%.

2. Raw Material Supply and Sustainable Development

Expansion of Artificial Planting Bases: Wild yew resources are limited, and the area of artificial planting is expanding at an average annual rate of 24%, reaching 128,000 mu in 2023. Yunnan and Sichuan will together contribute 65% of the national raw material supply. Construction of the "10,000 Mu Yew GAP Base" project has commenced, with an expected raw material self-sufficiency rate of 70% by 2027. Driven by environmental policies: Supercritical CO₂ extraction technology reduces solvent pollution, aligns with sustainable development requirements, and promotes the industry's transition to green manufacturing.

The taxifolin market is experiencing rapid growth driven by explosive demand in the pharmaceutical sector, rising consumption of health supplements and cosmetics, and technological advancements and cost optimization.

This report presents a comprehensive overview of the global Taxifolin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Below 92%
• 92%-98%
• Above 98%

Segment by Application

• Food and Beverages
• Healthcare
• Cosmetics
• Agriculture
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Taxifolin market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Food and Beverages, Healthcare, Cosmetics evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact